JCR Pharmaceuticals Co., Ltd. (4552.T) JPX

Currency In JPY

JCR Pharmaceuticals Co., Ltd.

Address

3-19 Kasuga-cho

Ashiya, 659-0021

Japan

Phone

81 7 9732 8591

Website

https://www.jcrpharm.co.jp

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

934

First IPO Date

November 17, 2005

Key Executives

Name	Title	Pay	Year Born
Takafumi Shimizu	Director of Marketing Dept. & Sales Division	0	N/A
Katsuya Nishino	Executive Vice President	0	1956
Hiroyuki Fukuya	Exec Off, Dir of Legal & Compliance, Internal Control Dept and Chief Legal & Compliance Off	0	N/A
Hiroyuki Sonoda	President, Chief Scientific Officer & Representative Director	0	1978
Shin Ashida	Founder & Director	0	1943
Yutaka Honda	Senior Managing Executive Officer, Exec Director of Administration Div. & Head of Exec Office	0	N/A
Yoshihiro Ota	Director of Accounting Department & Corporate Strategy Department (Finance)	0	N/A
Hiroshi Yoshimoto	Senior Advisor	0	1951
Shinji Okamoto	Director of Human Resources Department & Administration Division	0	N/A
Toru Ashida	Chairman of the Board	0	1968

Description

JCR Pharmaceuticals Co., Ltd. is a specialized pharmaceutical firm primarily engaged in the creation, development, manufacturing, international trade, and distribution of medicinal products, regenerative therapies, and active pharmaceutical ingredients within Japan. The company offers a range of therapeutic solutions, including GROWJECT, which addresses growth hormone deficiency and short stature; IZCARGO, prescribed for Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion, utilized in the management of Fabry disease; and TEMCELL HS Inj, employed to treat acute graft-versus-host disease. Beyond its current offerings, JCR Pharmaceuticals is also developing Epoetin Alfa BS and Darbepoetin Alfa BS Injections, both intended for the treatment of renal anemia. Furthermore, the company markets various medical devices and laboratory instruments. Founded in 1975, its headquarters are situated in Ashiya, Japan.